Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02750813 · ClinicalTrials.gov registry record · NA
ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®
A NA study, sponsored by Alcon, a Novartis Company.
- Completed
- Registry status
- NA
- Development phase
- 252
- Enrollment target
NCT02750813 is a NA study that has completed, run by Alcon, a Novartis Company. The registered enrollment target is 252 participants.
The verdict
NCT02750813, a NA study, has completed, sponsored by Alcon, a Novartis Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the lens fit characteristics, specifically lens centration, of ACUVUE® OASYS® 1-DAY (AO1D) contact lenses and DAILIES TOTAL1® (DT1) contact lenses.
Interventions
- DEVICE Delefilcon A contact lenses
- DEVICE Senofilcon A contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2016-04-27 |
| Est. Completion | 2016-08-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02750813
The ClinicalTrials.gov registry entry for NCT02750813 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon, a Novartis Company, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Delefilcon A contact lenses is the first listed.
NCT02750813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02750813 about?
NCT02750813 is a clinical study titled "ACUVUE® OASYS® 1-DAY vs DAILIES TOTAL1®". The purpose of this study is to compare the lens fit characteristics, specifically lens centration, of ACUVUE® OASYS® 1-DAY (AO1D) contact lenses and DAILIES TOTAL1® (DT1) contact lenses.
What is the current status of trial NCT02750813?
This trial is currently completed. It is a NA study. The enrollment target is 252 participants. The study started on 2016-04-27. Estimated completion is 2016-08-17.
What interventions are being tested in trial NCT02750813?
The interventions under investigation include: Delefilcon A contact lenses (DEVICE), Senofilcon A contact lenses (DEVICE).
Who is sponsoring clinical trial NCT02750813?
This trial is sponsored by Alcon, a Novartis Company, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.